Test Price
1,500 AED✅ Home Collection Available
Chimerism Split Cell Analysis - Myeloid Cell (CD15) in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- Clinical Guidance: Complimentary telephone post-test clinical interpretation by DHA-licensed consultant.
- Insurance Direct Billing: Verify your coverage instantly via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This highly specialised PCR-STR fragment assay quantifies donor/recipient chimerism in CD15+ myeloid cells post-haematopoietic stem cell transplant, essential for engraftment monitoring and minimal residual disease detection.
| Feature | Chimerism Split Cell (CD15) | Conventional Chimerism (Unfractionated) |
|---|---|---|
| Cell Target | Myeloid lineage (CD15), precise engraftment status | Whole blood, may mask mixed chimerism |
| Method | Multiplex PCR-STR with fluorescent capillary electrophoresis | PCR-STR or FISH; lower resolution |
| Turnaround Time | 7 working days (sample by 11 AM) | Often 10-14 days |
Physician Insight & Safety Protocols
“Chimerism analysis is a dynamic indicator; I always correlate results with clinical context—trends matter more than a single number. Please maintain your prescribed immunosuppressive regimen unless advised otherwise by your transplant team. Our role is to empower you with data, not to replace your physician’s judgment.” — Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403.
Advisory & Safety Notice
Critical Pre-Analysis Guidance
Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Modifying immunosuppressants can precipitate graft rejection or GVHD.
Exclusion Criteria & Emergency Red Flags
- Home Collection Safety: Not recommended if patient has unstable vital signs, active infection with fever >38.5°C, or platelet count <20,000/µL (risk of bleeding).
- ER Red Flags: Seek immediate medical attention if you experience sudden bruising, uncontrolled bleeding, severe abdominal pain, or confusion post-transplant.
- Paediatric/Minor Consent: Per Federal Decree-Law No. 4 of 2016 on Medical Liability, testing for individuals under 18 requires documented legal guardian consent.
- Sample Integrity: Bone marrow aspirate must be collected by a qualified physician; our phlebotomists only draw peripheral blood.
- Failure to indicate accurate Date of Bone Marrow Transplant will delay reporting.
Patient FAQ & Clinical Guidance
1. What is the purpose of splitting chimerism into myeloid (CD15) fraction?
Splitting myeloid chimerism using CD15 allows precise assessment of donor-derived myelopoiesis, revealing early graft failure even when total leukocyte chimerism appears normal—critical for timely clinical intervention.
2. How long does it take to receive results?
Nationally, our report is delivered within 7 working days from receipt of properly collected sample. Expedited reporting is available upon request via WhatsApp.
3. Do I need to fast before my home blood draw?
No fasting required—simply hydrate well and have your transplant date card handy for the phlebotomist.
4. Can the test be performed on a sample collected at home?
No, this test requires a hospital-based extraction due to the invasive nature of bone marrow aspiration. Peripheral blood draws are only conducted within accredited hospital facilities for safety.
UAE Regulatory & Data Privacy Adherence
All personal data handling complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical testing safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. Your data is encrypted, access-controlled, and used exclusively for diagnostic purposes.
Clinical & Logistical Metadata
| Test Name | Chimerism Split Cell Analysis - Myeloid Cell (CD15) |
| Price (AED) | 1,500 |
| Turnaround Time | 7 working days |
| Sample Type / Matrix | Peripheral Blood or Bone Marrow Aspirate |
| Methodology Used | Multiplex PCR-STR with Fluorescent Capillary Electrophoresis |
| ICD-10-CM Code | Z94.9 |
| LOINC Code | 95008-2 |
| DHA Facility License & Laboratory Address | License 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians